www.medicaldesignandoutsourcing.com JULY 2022
FDA CAN’T EXPLAIN DROP IN DEVICE RECALLS, BUT EXPERTS POINT TO COVID DISRUPTION
DEXCOM CEO EXPECTS ‘SCIENCE BOOM’ WITH CGM, AUTOMATED INSULIN DELIVERY
![]()
www.medicaldesignandoutsourcing.com JULY 2022
FDA CAN’T EXPLAIN DROP IN DEVICE RECALLS, BUT EXPERTS POINT TO COVID DISRUPTION
DEXCOM CEO EXPECTS ‘SCIENCE BOOM’ WITH CGM, AUTOMATED INSULIN DELIVERY